- Home
- IGIC vs AVDL Comparison
IGIC vs AVDL Comparison
Compare IGIC & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGIC
- AVDL
- Stock Information
- Founded
- IGIC 2001
- AVDL 2015
- Country
- IGIC Jordan
- AVDL Ireland
- Employees
- IGIC N/A
- AVDL N/A
- Industry
- IGIC Property-Casualty Insurers
- AVDL Biotechnology: Pharmaceutical Preparations
- Sector
- IGIC Finance
- AVDL Health Care
- Exchange
- IGIC Nasdaq
- AVDL Nasdaq
- Market Cap
- IGIC 1.0B
- AVDL 786.3M
- IPO Year
- IGIC N/A
- AVDL 1996
- Fundamental
- Price
- IGIC $25.46
- AVDL $8.55
- Analyst Decision
- IGIC Buy
- AVDL Strong Buy
- Analyst Count
- IGIC 3
- AVDL 6
- Target Price
- IGIC $23.67
- AVDL $20.00
- AVG Volume (30 Days)
- IGIC 77.2K
- AVDL 1.8M
- Earning Date
- IGIC 02-25-2025
- AVDL 03-03-2025
- Dividend Yield
- IGIC 0.39%
- AVDL N/A
- EPS Growth
- IGIC 32.83
- AVDL N/A
- EPS
- IGIC 3.04
- AVDL N/A
- Revenue
- IGIC $506,160,000.00
- AVDL $138,160,000.00
- Revenue This Year
- IGIC N/A
- AVDL $515.63
- Revenue Next Year
- IGIC $6.64
- AVDL $49.32
- P/E Ratio
- IGIC $8.17
- AVDL N/A
- Revenue Growth
- IGIC 10.67
- AVDL 1523.50
- 52 Week Low
- IGIC $11.51
- AVDL $7.39
- 52 Week High
- IGIC $27.00
- AVDL $19.09
- Technical
- Relative Strength Index (RSI)
- IGIC 60.28
- AVDL 44.82
- Support Level
- IGIC $24.28
- AVDL $7.40
- Resistance Level
- IGIC $25.74
- AVDL $8.01
- Average True Range (ATR)
- IGIC 0.63
- AVDL 0.33
- MACD
- IGIC 0.12
- AVDL 0.14
- Stochastic Oscillator
- IGIC 87.37
- AVDL 97.51
About IGIC International General Insurance Holdings Ltd.
International General Insurance Holdings Ltd is an international specialist commercial insurer and a reinsurer, underwriting a diverse portfolio of specialty lines. The company operates in a portfolio of Energy, Property, Construction, Engineering, Ports and terminals, Financial Institutions, General Aviation, Professional Indemnity, Casualty, Directors and Officers, Political Violence, Forestry, and Treaty Reinsurance. Its operating segment includes Specialty Longtail; Specialty Short tail and Reinsurance.
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.